Rationale: Developmental patterns of lung function during childhood may have major implications for our understanding of the pathogenesis of respiratory disease throughout life.
between early life lung function and subsequent respiratory disease. Diminished lung function in early infancy is one of the predisposing factors for early childhood wheezing (2, 3) , and children with flow limitation in infancy are more likely to have reduced lung function at ages 6 and 11 years (4), and into early adulthood (5, 6 ). However, most such studies do not include lung function measures between infancy and age 6 years, in part because of the difficulties in measuring lung function in preschool-age children. The most common method of lung function assessment in older children is spirometry, which measures FEV 1 , FVC, and other parameters using forced expiratory maneuvers. However, methods that require active cooperation are often difficult for preschool children to perform consistently and reproducibly, because many cannot produce adequate forced breathing maneuvers (7) . For younger children, the techniques that can be performed during tidal breathing are more practical (7) . One such method is measurement of specific airway resistance (sRaw) using plethysmography (8) (9) (10) (11) (12) (13) , which can be a useful measure in clinical practice and research studies (11) . We have previously shown that as early as age 3 years, sRaw differs between children with a history of wheezing and those without (9) , and higher sRaw at age 3 years is associated with subsequent persistence of wheezing (14) . In childhood, sRaw is considered to be independent of age, height, and sex, thus facilitating the interpretation of longitudinal measurements in individual subjects (5, 8, 12, 13) . Previous data from our group indicated a possible increase in sRaw through early childhood (14) . However, no longitudinal studies have as yet addressed this important issue. Trajectory and 95% confidence intervals of specific airway resistance (sRaw) measurements over time. (A) Sex; on average, boys had a higher sRaw value than girls, and a significantly higher rate of change in sRaw over time than girls. (B) Atopy phenotypes (no latent atopic vulnerability and multiple early atopic vulnerability); on average, children with multiple early atopic vulnerability had poorer lung function. (C) Wheeze phenotypes (no wheezing and persistent wheezing); children with persistent wheeze had consistently poorer lung function (higher sRaw) than children who never wheezed, and a significantly higher rate of deterioration in lung function (increase in sRaw). (D) Wheeze and asthma exacerbations; wheezers who experienced exacerbation had significantly poorer lung function than children who never wheezed. There was no difference in the rate of change in lung function over time. n = number of children in each group with at least one measurement at a single time point.
Based predominantly on crosssectional data, various factors have been associated with lung function impairment in childhood, including sex (15), low birth weight (16) , maternal smoking during pregnancy (14, 17) , maternal asthma (18), child's atopic status (9) , and among children with atopy high exposure to sensitizing allergens (19, 20) . Genetic factors also have an important role; for example, we have recently reported significant associations between genetic variants in VEGF-A with lung function (including sRaw) measured during childhood, with the effect persisting into adulthood (21) . Gene-by-environment interactions may also play a role in the developmental pathway of lung function (22) . These studies have laid important foundations for the understanding of the physiologic, genetic, and environmental factors associated with diminished lung function. However, there are no existing studies investigating the developmental trajectories of lung function from early childhood, in which the same measure of lung function was assessed on more than two occasions.
We hypothesized that within a population of children, there are several different trajectories of lung function, each with differing predictors. We capitalized on the unique data collection in the Manchester Asthma and Allergy Study, in which measurement of sRaw was performed at four time points from preschool to mid-school age, to investigate factors associated with a change in lung function during childhood. We aimed to establish (1) whether sRaw increases, remains stable, or decreases over time; (2) the characteristics that predict the crosssectional differences among children, and changes in sRaw over time; and (3) to identify a single multilevel model to describe the association between sRaw and these characteristics over time. We used multilevel longitudinal models to explore plausible relations between developmental trajectories of lung function and age, sex, height, weight, pet ownership, family history of asthma, atopy, and various phenotypes of respiratory disease during childhood to identify groups of children in whom lung function diminishes over time. Some of the results of these studies have been previously reported in the form of an abstract (23) .
Methods

Study Population
Manchester Asthma and Allergy Study is a population-based birth cohort (24) . Subjects were recruited prenatally and followed prospectively until age 11 years. Both parents were skin prick tested to ascertain atopic sensitization, and completed questionnaires to document personal history of asthma. The study was approved by the local ethics committee; parents gave written informed consent.
Data Sources
Clinical follow-up. A series of risk factors including maternal smoking during (25) . We assessed atopy by skin prick tests. We also measured specific serum IgE to common inhalant and food allergens (ImmunoCAP; Phadia, Uppsala, Sweden). Lung function measurement. We measured sRaw at ages 3, 5, 8, and 11 years during tidal breathing using a constant volume whole-body plethysmography (9, 14, 19, 26) . Children were symptom-free at the time of assessment of lung function. Short-acting b 2 -agonists were withheld for at least 4 hours and long-acting for at least 24 hours before testing. A detailed description of methods is provided in the online supplement.
Primary care data extraction. We extracted all data from primary care medical records, including wheeze episodes, prescriptions of asthma medications, oral corticosteroid prescriptions, emergency department admissions, and asthma-and wheeze-related hospitalizations (27) .
Definition of Predictive Phenotypes
Current wheeze. A positive answer to the question "Has your child had wheezing or whistling in the chest in the last 12 months" defined current wheeze.
Wheeze phenotypes. We used prospectively collected data to assign children into different wheeze phenotypes (14, 28) . We used the following classification: No wheezing (no wheeze at any time point), Transient early wheezing (wheezing during the first 3 yr, with no wheezing after age 3 yr), Late-onset wheezing (no wheeze during the first 3 years, reported wheezing at age 5 yr or later), and Persistent wheezing (wheezing throughout the childhood).
Severe asthma and wheeze exacerbations. This was defined by receipt of oral steroids for at least 3 days or admission to hospital or emergency department visit because of asthma requiring oral steroid use (ascertained from medical notes) (29) . This definition was also applied to children younger than age 6 years.
Hospital admission. This was defined as admission to hospital for asthma or wheeze (from medical notes).
Atopic sensitization. This was defined by weal diameter 3 mm greater than negative control to at least one allergen.
Phenotypes of atopy. In recent studies we used machine learning methods applied Definition of abbreviation: sRaw = specific airway resistance. sRaw (mean, SE) for children in the reference group (no symptoms, lung function at age 3 yr) is presented in the first line. For each model we present the estimated difference in sRaw among children with a given characteristic (e.g., current wheeze in Model A) compared with children in the reference group. The estimate of age shows the expected increase in sRaw for every year increase in age.
to longitudinal skin prick tests and IgE data to ascertain atopy phenotypes (30, 31) , moving from a dichotomous (atopic/ nonatopic) to a five-class model, where each class (phenotype) reflected distinct patterns of sensitization (32) . We used these five classes as phenotypes of atopy: (1) nonatopic, (2) dust mite, (3) non-dust mite, (4) multiple early, and (5) multiple late (30) .
Statistical Analysis
We used multilevel models to investigate factors associated with differences in sRaw between children, and changes in sRaw over time. We fitted random coefficient models to investigate both the time-varying and time-invariant (fixed) covariates (see Table  E1 in the online supplement), which predicted differences in sRaw. By including an interaction term in the random coefficients model, we extended these models to investigate whether each of these factors were also predictors of change in sRaw over time. After fitting various submodels of predictors of interest individually, we combined them in a realistically complete mode of change in sRaw over time, selected on the basis of likelihood ratio tests of nested models. All statistical analysis was performed using Stata 12.2 (Stata Statistical Software; StataCorp LP, College Station, TX). Missing data mechanisms were investigated using logistic regression. sRaw and the covariates were assumed to be missing at random. Based on this assumption, multiple imputation using chained equations was performed using the ice package in Stata (33, 34) . Each of the 100 imputed datasets was then analyzed in the usual way, and the parameter estimates were combined using Rubin rule (35, 36) . Similar results were obtained from analyses using data from complete cases compared with the imputed datasets (data not shown, available on request).
Results
Participant Flow and Demographics
We analyzed data from 1,051 of 1,184 children in the cohort (we excluded 113 who were randomized to the environmental intervention) (37, 38) . sRaw was measured in 560 children at age 3, 829 at age 5, 786 at age 8, and 644 at age 11 years; 350 had data at all four time points, 668 at three or more, and 846 children had at least two sRaw measurements. Data were transcribed from primary care medical records of 814 of 1,051 (77.5%) children. Table E2 shows the proportion of observations for each variable investigated for association with sRaw at each time point. There were no significant differences in demographics, wheeze, and atopy for children with and without missing sRaw data (see Table E3 ).
Factors Affecting Mean Differences and Factors Affecting Rate of Change in sRaw
Although this study focuses on predictors of longitudinal change in sRaw over time, for completion we present cross-sectional associations at each time point in Table E4 .
Age, sex, anthropometric characteristics, family history, and environmental exposures. There was a significant increase in sRaw over time in the whole population (see Table E5 , Model A). Longitudinal analysis revealed that boys had significantly higher sRaw during childhood than girls (mean difference, 0.08 kPa $ s 21 ; 95% confidence interval [CI], 0.049-0.111; P , 0.001) (see Table E5 , Model B), but also a faster rate of increase over time ( Figure 1A ; see Table E5 , Model C). For girls, sRaw increased by 0.017 kPa $ s 21 per year (95% CI, 0.011-0.023; P , 0.001), whereas in boys this increase was significantly greater (mean difference, 10.011 kPa $ s 21 ; 95% CI, 0.003-0.019; P = 0.012), with a slope of 0.028 (0.017 1 0.011) kPa $ s 21 per year. We calculated z scores for height, weight, and body mass index using published UK standards (39) to investigate their associations with lung function. As univariate predictors, weight and height were significantly associated with sRaw, but there was no significant association with body mass index standard deviation score (weight adjusted for height, age, and sex) (see Table E6 ).
The effect of parental atopic sensitization and asthma is presented in Table E7 . Maternal asthma was significantly associated with higher sRaw in offspring (mean difference, 0.048 kPa $ s 21 ; 95% CI, 0.005-0.091; P = 0.03) (see Table E7 , Model C).
There was no evidence of the statistically significant association between sRaw and maternal smoking during pregnancy (P = 0.25), at birth (P = 0.44), or time-varying smoking exposure at ages 3-11 years (P = 0.43) (see Table E8 ). There was no significant association between dog or cat ownership and sRaw (P = 0.34 and P = 0.68, respectively) (see Table E9 ), and no significant interaction between pet sensitization (assessed using skin prick tests) and pet ownership (cat, P = 0.59; dog, P = 0.99).
Atopic sensitization. Sensitized children had significantly higher sRaw than those who were not sensitized (mean difference, 0.052 kPa $ s
21
; 95% CI, 0.020-0.084; P = 0.002) ( Table 1 , Model A); however, the rate of change of sRaw over time did not differ between the groups (P = 0.16).
When we investigated different phenotypes of atopy (30, 31), we found that only children with multiple early phenotype had significantly poorer lung function than those who were nonatopic (mean difference, 0.116 kPa $ s 21 ; 95% CI, 0.065-0.168; P , 0.001) ( Figure 1B) , with no significant difference between other atopy phenotypes (Table 1 , Model B; see Figure E1 ). Including a term for interaction with time (Table 1 , Model C) revealed that the differences in sRaw increased with age between nonatopic compared with multiple early ( Figure 1B , P = 0.032) and multiple late atopy phenotype (P = 0.047), with no differences in the rate of change of sRaw over time observed between other phenotypes of atopy (see Figure E1) .
Wheeze and asthma. Contemporaneous wheezing (i.e., current wheeze at the same time point when lung function was measured) was significantly associated with sRaw; children who wheezed had significantly higher sRaw compared with those who did not (mean difference, 0.068 kPa $ s
; 95% CI, 0.032-0.105; P , 0.001) ( Table 2 , Model A). The use of asthma medication and physician-diagnosed asthma were also significant indicators of poorer lung function (both P , 0.001) ( Table 2 , Models B and C). However, there was no significant difference in the rate of change of sRaw over time between those who do and do not wheeze (or between those with and without asthma).
Different longitudinal patterns were observed when we used wheeze phenotypes as predictors ( ; 95% CI, 0.003-0.019; P = 0.009) ( Figure 1C ). Children with transient and late-onset wheeze had significantly poorer lung function than those who never wheezed, but the magnitude of difference was lower than for those with persistent wheeze, and the change over time was not significantly different (Table 2 ; see Figure E2 ).
Severe exacerbations and hospital admissions for asthma and wheeze.
Children with wheeze and asthma exacerbation had significantly poorer lung function than those with wheeze and no exacerbation (P , 0.001), and children who have never wheezed (P , 0.001) ( Figure 1D , Table 3 , Model A). Lung function was progressively worse with the increasing number of exacerbations (Table 3 , Model B; see Figure E3 ). Similar trends were seen for asthma and wheeze hospital admissions (see Table E10 , Figures  E4 and E5) . Children who within the first 3 years of life had severe exacerbation or were admitted to hospital had significantly poorer lung function throughout childhood (Table 3 , Model C; see Figures  E6 and E7 ).
Prototypical Trajectories for Change in Lung Function over Time
When putting predictors that we found to be significantly associated with sRaw in a multivariable longitudinal regression model, the set of predictors that best described the data were sex, wheeze phenotypes, and atopy phenotypes.
Persistent wheeze and male sex were significant predictors of increase in sRaw over time (Table 4 ). Height and weight were no longer significant independent predictors of sRaw in the multivariate regression model (see Table E11 ). Prototypical trajectories for change in sRaw over time for different hypothetical groups of children are shown in Figure 2 , and are based on predicted values of the multivariate model with sex, wheeze phenotypes, and atopy phenotypes presented in Table 4 . Girls without atopy who have never wheezed have the lowest sRaw (i.e., the best lung function) during childhood. Boys with persistent wheeze and multiple early atopy have the highest risk of diminished lung function during childhood.
Discussion Principal Findings
To the best of our knowledge, this is the first study to investigate factors associated with longitudinal change in sRaw during childhood. We set out to describe the patterns and predictors of lung function development from preschool to mid-school age, using sRaw measured at age 3 years, and repeated at ages 5, 8, and 11 years. Our results indicate that contrary to the commonly held view that sRaw is independent of age and sex (5, 8, 12, 13) , this measure of lung function within individual subjects increases significantly with age during the prepubertal stage of life. Furthermore, there are clear differences in the profile of sRaw over time between males and females. Sex is not only a significant predictor of sRaw at each time point, but boys and girls also have a different rate of change in sRaw over time, with boys having significantly accelerated increase compared with girls from age 8 to 11 years. These differences in trajectory by sex are striking and are not caused by the higher prevalence of wheeze in boys than girls, because the trajectories for nonwheezing girls and nonwheezing boys show a similar divergence over time. Other independent predictors of sRaw trajectories were Definition of abbreviation: sRaw = specific airway resistance. sRaw (mean, SE) for children in the reference group (no wheeze, lung function at age 3 yr) is presented in the first line for each model. For each model we present the estimated difference in sRaw among children with a given characteristic (e.g., exacerbation ever in Model A) compared with children in the reference group. The estimate of age shows the expected increase in sRaw for every year increase in age.
phenotypes of wheeze and atopy. There was an interaction between persistent wheeze and age, with trajectories of persistent wheezers differing from those of nonwheezers and indicating a loss in lung function over time. We observed similar interaction between one of the atopy phenotypes (multiple early atopy) and age, with trajectory that differed from those of children without atopy. In contrast, there was no significant effect of other wheeze or atopy phenotypes on the rate of change in lung function over time. The highest sRaw profiles (i.e., poorest lung function) were seen among children who had suffered severe asthma exacerbations.
Strengths and Limitations
One strength of our study is the large sample of children, representative of the local population, with a wealth of longitudinal measures available allowing us to model change in lung function throughout childhood. This enabled us to measure within-individual variation, contrasting with previous studies, which have been predominantly cross-sectional (11) . Previous studies have indicated the difficultly in standardizing sRaw measurements in practice, and the large variability in measures introduced by differences in assessment tools for evaluating sRaw (9, 10 ). In the current study, sRaw was measured at each time point using the same equipment, the same methodology, and conducted by the same respiratory physiologist at each follow-up, reducing possible inconsistencies caused by methodologic and technical differences (11) . The limitation of our study is the lack of infant lung function data for most study participants (V'maxFRC was assessed in ,5% of the study participants [3] ), and we therefore made no attempt to use these data in the analysis. We were thus unable to track changes in lung function from earlier than age 3 years, and establish conclusively the causal mechanisms (6, 40) . However, it is of note that the rapid thoracic compression technique that we (3) and others (2, 4, 6, 40) used to measure VmaxFRC in infancy may not be directly comparable with the measures of lung function during childhood using plethysmography.
We acknowledge that we have conducted multiple statistical tests. However, because the factors that we investigated as predicators of trajectories of lung function are biologically plausible and based on the published literature, we have not adjusted our analysis for multiples testing.
Interpretation
Wheezing illness is associated with poorer lung function; it is not entirely clear whether this deficit in lung function occurs as a consequence of wheeze, or predisposes to it, or both. A previous study from the Tucson cohort (with measurements of lung function available at ages 4 wk and 6 yr) suggested that for persistent wheezers the deficit in lung function is not present soon after birth, but is acquired by age 6 years, whereas children with transient early wheeze have diminished lung function shortly after birth (22) . Although we are unable to investigate lung function in infancy in our analysis, we have shown a deficit in sRaw by age 3 years in those with transient and persistent wheeze (but not late-onset wheeze). This may give us a further indication that the important lung function deficits occur within the first 3 years of life. Furthermore, our longitudinal data demonstrate that not only do those with persistent wheeze have the poorest lung function, but their individual trajectories diverge from all other groups over time, suggesting Definition of abbreviation: sRaw = specific airway resistance. sRaw (mean, SE) for the reference group (girls with no wheeze and no atopy) is presented in the first line. The estimate of age shows the expected increase in sRaw for every year increase in age in the reference group. We present estimated differences in sRaw in each of the wheeze and atopy phenotypes compared with the reference group. For predictors of rate of change over time (i.e., interactions with time), the estimated differences (SE) indicate mean differences in the rate of change over time for boys compared with girls and children with persistent wheeze compared with those with no wheeze.
ORIGINAL ARTICLE a significant loss of lung function during the period from age 3 to 11 years. The difference in lung function between children who wheeze, but have no exacerbations, and those who have exacerbations indicates that it is not merely wheeze, but persistent, severe wheeze that has an adverse effect on lung function. Lung function was progressively worse with the increasing number of exacerbations and hospital admissions. This is consistent with the results of our recent study in which children with persistent troublesome wheeze (defined using latent class analysis on both parental and primary-care reports of wheeze, and characterized by frequent exacerbations) had significantly greater increase in sRaw over time compared with persistent wheezers with controlled disease (27) . Similar to the findings on wheeze phenotypes, our data demonstrate that it is not just atopy, but a specific atopy phenotype that is associated with poor lung function (multiple early atopy, comprising approximately one-quarter of children conventionally defined as being atopic [30] ). The analysis indicated that there was no significant difference in lung function between the remaining three atopy phenotypes (i.e., approximately three-quarters of children with atopy), and children with no atopy. Children with both multiple early atopy and persistent wheeze are at an increased risk of poor lung function throughout childhood, with the effects more marked in boys than girls (Figure 2) .
We found that cat and dog ownership did not have a significant effect on lung function at any time point, or on change in lung function over time. In contrast to the previous cross-sectional findings (19, 20) , there was no evidence to indicate a significant interaction between allergenspecific sensitization and pet exposure on the development of lung function.
Conclusions
Our longitudinal study demonstrated that sRaw is not independent of age and sex, but that this measure of lung function within individual subjects increases significantly with age during the prepubertal period. Furthermore, there are differences in the trajectory of sRaw over time between boys and girls, with the accelerated increase in boys compared with girls. Continued follow-up during and after puberty would be important to ascertain whether this trend changes during this important developmental period in which sex switch in asthma prevalence occurs. We observed distinct associations of sRaw with different wheeze and atopy phenotypes, with children with multiple early atopy, persistent wheeze, and frequent severe exacerbations being at an increased risk of diminished lung function throughout childhood, and a progressive loss of lung function during the period from age 3 to 11 years. These effects were more marked in boys than girls. n Author disclosures are available with the text of this article at www.atsjournals.org.
